Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
279.8 USD | +0.19% | +1.41% | -13.34% |
29/04 | RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474 | MT |
26/04 | Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.34% | 7.98B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio Rad Laboratories : Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $930 From $735, Maintains Overweight Rating